rs2709591
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_003887.3(ASAP2):c.1161-17T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.58 in 1,613,672 control chromosomes in the GnomAD database, including 281,056 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.65 ( 33982 hom., cov: 32)
Exomes 𝑓: 0.57 ( 247074 hom. )
Consequence
ASAP2
NM_003887.3 intron
NM_003887.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.998
Publications
19 publications found
Genes affected
ASAP2 (HGNC:2721): (ArfGAP with SH3 domain, ankyrin repeat and PH domain 2) This gene encodes a multidomain protein containing an N-terminal alpha-helical region with a coiled-coil motif, followed by a pleckstrin homology (PH) domain, an Arf-GAP domain, an ankyrin homology region, a proline-rich region, and a C-terminal Src homology 3 (SH3) domain. The protein localizes in the Golgi apparatus and at the plasma membrane, where it colocalizes with protein tyrosine kinase 2-beta (PYK2). The encoded protein forms a stable complex with PYK2 in vivo. This interaction appears to be mediated by binding of its SH3 domain to the C-terminal proline-rich domain of PYK2. The encoded protein is tyrosine phosphorylated by activated PYK2. It has catalytic activity for class I and II ArfGAPs in vitro, and can bind the class III Arf ARF6 without immediate GAP activity. The encoded protein is believed to function as an ARF GAP that controls ARF-mediated vesicle budding when recruited to Golgi membranes. In addition, it functions as a substrate and downstream target for PYK2 and SRC, a pathway that may be involved in the regulation of vesicular transport. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.881 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ASAP2 | ENST00000281419.8 | c.1161-17T>C | intron_variant | Intron 13 of 27 | 1 | NM_003887.3 | ENSP00000281419.3 | |||
| ASAP2 | ENST00000315273.4 | c.1161-17T>C | intron_variant | Intron 13 of 26 | 1 | ENSP00000316404.4 | ||||
| ASAP2 | ENST00000641030.1 | c.699-17T>C | intron_variant | Intron 9 of 10 | ENSP00000493293.1 | |||||
| ASAP2 | ENST00000471687.1 | n.487-17T>C | intron_variant | Intron 2 of 2 | 4 |
Frequencies
GnomAD3 genomes AF: 0.646 AC: 98191AN: 151932Hom.: 33929 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
98191
AN:
151932
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.550 AC: 138197AN: 251370 AF XY: 0.550 show subpopulations
GnomAD2 exomes
AF:
AC:
138197
AN:
251370
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.574 AC: 838279AN: 1461622Hom.: 247074 Cov.: 53 AF XY: 0.573 AC XY: 416692AN XY: 727106 show subpopulations
GnomAD4 exome
AF:
AC:
838279
AN:
1461622
Hom.:
Cov.:
53
AF XY:
AC XY:
416692
AN XY:
727106
show subpopulations
African (AFR)
AF:
AC:
30253
AN:
33474
American (AMR)
AF:
AC:
22081
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
AC:
16621
AN:
26136
East Asian (EAS)
AF:
AC:
6251
AN:
39696
South Asian (SAS)
AF:
AC:
46765
AN:
86250
European-Finnish (FIN)
AF:
AC:
28203
AN:
53420
Middle Eastern (MID)
AF:
AC:
3779
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
649014
AN:
1111766
Other (OTH)
AF:
AC:
35312
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
19115
38231
57346
76462
95577
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
17752
35504
53256
71008
88760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.647 AC: 98302AN: 152050Hom.: 33982 Cov.: 32 AF XY: 0.639 AC XY: 47471AN XY: 74326 show subpopulations
GnomAD4 genome
AF:
AC:
98302
AN:
152050
Hom.:
Cov.:
32
AF XY:
AC XY:
47471
AN XY:
74326
show subpopulations
African (AFR)
AF:
AC:
36869
AN:
41484
American (AMR)
AF:
AC:
8705
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
2222
AN:
3466
East Asian (EAS)
AF:
AC:
846
AN:
5172
South Asian (SAS)
AF:
AC:
2591
AN:
4818
European-Finnish (FIN)
AF:
AC:
5382
AN:
10554
Middle Eastern (MID)
AF:
AC:
214
AN:
294
European-Non Finnish (NFE)
AF:
AC:
39528
AN:
67958
Other (OTH)
AF:
AC:
1331
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1573
3147
4720
6294
7867
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
750
1500
2250
3000
3750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1382
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.